Results 271 to 280 of about 1,616,748 (350)

The Need for a Revision of Fluoroquinolone Breakpoints for Interpretation of Antimicrobial Susceptibility Testing of Feline Bacterial Isolates

open access: yesJournal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT The fluoroquinolone antimicrobial agents, enrofloxacin and marbofloxacin, were approved in the United States for cats in 1990 and 2001, respectively. In 2023, revised breakpoints for testing isolates from dogs were published. These canine breakpoints are discordant with the current feline breakpoints.
Mark G. Papich   +2 more
wiley   +1 more source

Clinical scoring system to differentiate melioidosis from other documented causes of community-acquired bacterial pneumonia: a retrospective cohort study. [PDF]

open access: yesInfection
Gupta N   +8 more
europepmc   +1 more source

Time series differences in coagulopathy in mechanically ventilated COVID-19 and bacterial pneumonia patients: a nationwide observational study in Japan. [PDF]

open access: yesThromb J
Hisamune R   +14 more
europepmc   +1 more source

Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective study. [PDF]

open access: yesCrit Care
Giacobbe DR   +61 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy